» Articles » PMID: 35977966

Human Milk Oligosaccharide 2'-fucosyllactose Promotes Melanin Degradation Via the Autophagic AMPK-ULK1 Signaling Axis

Overview
Journal Sci Rep
Specialty Science
Date 2022 Aug 17
PMID 35977966
Authors
Affiliations
Soon will be listed here.
Abstract

There is still an unmet need for development of safer antimelanogenic or melanin-degrading agents for skin hyperpigmentation, induced by intrinsic or extrinsic factors including aging or ultraviolet irradiation. Owing to the relatively low cytotoxicity compared with other chemical materials, several studies have explored the role of 2'-fucosyllactose (2'-FL), the most dominant component of human milk oligosaccharides. Here, we showed that 2'-FL reduced melanin levels in both melanocytic cells and a human skin equivalent three-dimensional in vitro model. Regarding the cellular and molecular mechanism, 2'-FL induced LC3I conversion into LC3II, an autophagy activation marker, followed by the formation of LC3II/PMEL autophagosomes. Comparative transcriptome analysis provided a comprehensive understanding for the up- and downstream cellular processes and signaling pathways of the AMPK-ULK1 signaling axis triggered by 2'-FL treatment. Moreover, 2'-FL activated the phosphorylation of AMPK at Thr172 and of ULK1 at Ser555, which were readily reversed in the presence of dorsomorphin, a specific AMPK inhibitor, with consequent reduction of the 2'-FL-mediated hypopigmentation. Taken together, these findings demonstrate that 2'-FL promotes melanin degradation by inducing autophagy through the AMPK-ULK1 axis. Hence, 2'-FL may represent a new natural melanin-degrading agent for hyperpigmentation.

Citing Articles

Effects of Human Milk Oligosaccharide 2'-Fucosyllactose Ingestion on Weight Loss and Markers of Health.

Ko J, Yoo C, Xing D, Chun J, Gonzalez D, Dickerson B Nutrients. 2024; 16(19).

PMID: 39408354 PMC: 11478354. DOI: 10.3390/nu16193387.


Effect of 2'-Fucosyllactose on Beige Adipocyte Formation in 3T3-L1 Adipocytes and C3H10T1/2 Cells.

Chen S, Fu Y, Wang T, Chen Z, Zhao P, Huang X Foods. 2023; 12(22).

PMID: 38002194 PMC: 10670332. DOI: 10.3390/foods12224137.


2'-Fucosyllactose Suppresses Angiogenesis and Alleviates Toxic Effects of 5-Fu in a HCT116 Colon Tumor-Bearing Model.

Li H, Wang B, Wang Y Molecules. 2022; 27(21).

PMID: 36364081 PMC: 9658278. DOI: 10.3390/molecules27217255.

References
1.
Szallasi A, Cortright D, Blum C, Eid S . The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov. 2007; 6(5):357-72. DOI: 10.1038/nrd2280. View

2.
Chin Y, Kim J, Kim J, Jung S, Seo J . Improved production of 2'-fucosyllactose in engineered Escherichia coli by expressing putative α-1,2-fucosyltransferase, WcfB from Bacteroides fragilis. J Biotechnol. 2016; 257:192-198. DOI: 10.1016/j.jbiotec.2016.11.033. View

3.
Jung S, Chin Y, Lee Y, Seo J . Enhanced production of 2'-fucosyllactose from fucose by elimination of rhamnose isomerase and arabinose isomerase in engineered Escherichia coli. Biotechnol Bioeng. 2019; 116(9):2412-2417. DOI: 10.1002/bit.27019. View

4.
Chan E . mTORC1 phosphorylates the ULK1-mAtg13-FIP200 autophagy regulatory complex. Sci Signal. 2009; 2(84):pe51. DOI: 10.1126/scisignal.284pe51. View

5.
Xie Z, Klionsky D . Autophagosome formation: core machinery and adaptations. Nat Cell Biol. 2007; 9(10):1102-9. DOI: 10.1038/ncb1007-1102. View